Herbert Herzog Selected Research

neuropeptide Y4 receptor

12/2013	PYY3-36 and pancreatic polypeptide reduce food intake in an additive manner via distinct hypothalamic dependent pathways in mice.
12/2009	Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Herbert Herzog Research Topics

Disease

34	Obesity 01/2022 - 04/2002
27	Body Weight (Weight, Body) 01/2022 - 05/2002
15	AIDS-Related Complex (ARC) 01/2022 - 04/2006
8	Weight Loss (Weight Reduction) 01/2016 - 09/2006
7	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2002
7	Insulin Resistance 04/2017 - 10/2006
6	Hyperphagia (Overeating) 01/2020 - 11/2006
5	Glucose Intolerance 01/2022 - 11/2011
5	Anorexia 12/2021 - 11/2007
5	Seizures (Absence Seizure) 09/2011 - 09/2005
4	Neoplasms (Cancer) 01/2016 - 11/2007
4	Epilepsy (Aura) 01/2012 - 04/2007
4	Weight Gain 11/2011 - 10/2005
3	Prader-Willi Syndrome (Syndrome, Prader-Willi) 04/2017 - 08/2011
3	Inflammation (Inflammations) 12/2012 - 11/2011
3	Osteoporosis 12/2012 - 12/2009
2	Cognitive Dysfunction 01/2022 - 07/2013
2	Pain (Aches) 12/2021 - 01/2017
2	MASS syndrome 01/2020 - 03/2015
2	Metabolic Diseases (Metabolic Disease) 01/2018 - 01/2017
2	Alzheimer Disease (Alzheimer's Disease) 01/2014 - 07/2013
2	Schizophrenia (Dementia Praecox) 03/2010 - 12/2006
2	Hyperinsulinism (Hyperinsulinemia) 11/2006 - 10/2006
2	Mood Disorders (Mood Disorder) 01/2006 - 07/2003
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Frailty 06/2021
1	Infections 01/2019
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2018
1	Hypoglycemia (Reactive Hypoglycemia) 01/2018
1	Hyperalgesia 01/2017
1	Visceral Pain 01/2017
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2016
1	Starvation 12/2016
1	Disease Progression 01/2016
1	Hyperthermia 01/2016
1	Bone Diseases (Bone Disease) 01/2016
1	Anxiety Disorders (Anxiety Disorder) 01/2016
1	Cachexia 01/2013

Drug/Important Bio-Agent (IBA)

28	Neuropeptide YIBA 01/2022 - 05/2002
16	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2006
13	Insulin (Novolin)FDA Link 01/2022 - 10/2006
10	Peptide YYIBA 11/2021 - 09/2006
9	LeptinIBA 01/2022 - 04/2002
9	Messenger RNA (mRNA)IBA 01/2018 - 06/2002
7	Dynorphins (Dynorphin)IBA 06/2014 - 04/2007
6	NeuropeptidesIBA 01/2022 - 04/2007
6	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 04/2021 - 06/2002
6	Peptides (Polypeptides)IBA 04/2021 - 11/2006
5	Hormones (Hormone)IBA 01/2014 - 12/2006
5	preproenkephalinIBA 01/2014 - 04/2006
4	Pharmaceutical PreparationsIBA 01/2016 - 01/2006
3	phenylalanyl- leucyl- phenylalanyl- glutaminyl- prolyl- glutaminyl- arginyl- phenylalaninamideIBA 01/2022 - 11/2021
3	CytokinesIBA 01/2019 - 11/2007
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2014 - 04/2006
3	GhrelinIBA 01/2012 - 07/2007
3	Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA 12/2009 - 05/2002
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2006
2	BIBO 3304IBA 11/2021 - 07/2012
2	Anabolic AgentsIBA 01/2018 - 01/2018
2	LigandsIBA 01/2017 - 06/2005
2	Triglycerides (Triacylglycerol)IBA 01/2015 - 02/2008
2	Opioid Analgesics (Opioids)IBA 06/2014 - 04/2007
2	neuropeptide Y4 receptorIBA 12/2013 - 12/2009
2	Neuroprotective AgentsIBA 09/2012 - 09/2011
2	LipidsIBA 08/2012 - 02/2008
2	CorticosteroneIBA 07/2012 - 09/2008
2	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2012 - 04/2007
2	Anti-Obesity Agents (Antiobesity Drugs)IBA 12/2009 - 03/2007
2	Kainic Acid (Kainate)IBA 04/2006 - 09/2005
1	Biological ProductsIBA 12/2021
1	ninjin'yoeitoIBA 06/2021
1	NeurotensinIBA 04/2020
1	MineralsIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2019
1	Small Nucleolar RNA (snoRNA)IBA 04/2017
1	allyl isothiocyanateIBA 01/2017
1	2,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA 01/2017
1	Peanut OilIBA 01/2017
1	CatecholaminesIBA 12/2016
1	trichlorosucrose (sucralose)IBA 12/2016
1	Cadherins (E-Cadherin)IBA 01/2016
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2016
1	bone resorption factorIBA 01/2016
1	SugarsIBA 01/2016
1	Nonesterified Fatty Acids (NEFA)IBA 01/2015
1	C-PeptideIBA 01/2015
1	Glucagon (Glukagon)FDA Link 01/2015
1	Adrenergic Agents (Adrenergic Drugs)IBA 08/2014
1	cocaine- and amphetamine-regulated transcript proteinIBA 01/2014
1	Dimenhydrinate (DMH)FDA LinkGeneric 12/2013
1	KynurenineIBA 11/2013
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 07/2013
1	Homer Scaffolding Proteins (Homer 1)IBA 07/2013
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 02/2013
1	Uncoupling Protein 1IBA 02/2013
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2012

Therapy/Procedure

6	Therapeutics 12/2018 - 11/2003
1	Glycemic Control 01/2022
1	Islets of Langerhans Transplantation 01/2022
1	Kampo Medicine (Kampo) 06/2021